105 related articles for article (PubMed ID: 18327812)
1. Decreased expression of methyl methansulfonate and ultraviolet-sensitive gene clone 81 (Mus81) is correlated with a poor prognosis in patients with hepatocellular carcinoma.
Wu F; Liu SY; Tao YM; Ou DP; Fang F; Yang LY
Cancer; 2008 May; 112(9):2002-10. PubMed ID: 18327812
[TBL] [Abstract][Full Text] [Related]
2. p53-induced RING-H2 protein, a novel marker for poor survival in hepatocellular carcinoma after hepatic resection.
Wang XM; Yang LY; Guo L; Fan C; Wu F
Cancer; 2009 Oct; 115(19):4554-63. PubMed ID: 19551892
[TBL] [Abstract][Full Text] [Related]
3. Increased DJ-1 and its prognostic significance in hepatocellular carcinoma.
Liu S; Yang Z; Wei H; Shen W; Liu J; Yin Q; Li X; Yi J
Hepatogastroenterology; 2010; 57(102-103):1247-56. PubMed ID: 21410067
[TBL] [Abstract][Full Text] [Related]
4. STC2 as a novel mediator for Mus81-dependent proliferation and survival in hepatocellular carcinoma.
Wu F; Li TY; Su SC; Yu JS; Zhang HL; Tan GQ; Liu JW; Wang BL
Cancer Lett; 2017 Mar; 388():177-186. PubMed ID: 27939696
[TBL] [Abstract][Full Text] [Related]
5. Genomic analysis reveals RhoC as a potential marker in hepatocellular carcinoma with poor prognosis.
Wang W; Yang LY; Huang GW; Lu WQ; Yang ZL; Yang JQ; Liu HL
Br J Cancer; 2004 Jun; 90(12):2349-55. PubMed ID: 15150600
[TBL] [Abstract][Full Text] [Related]
6. Downregulation of MAGI1 associates with poor prognosis of hepatocellular carcinoma.
Zhang G; Liu T; Wang Z
J Invest Surg; 2012 Apr; 25(2):93-9. PubMed ID: 21942217
[TBL] [Abstract][Full Text] [Related]
7. Increased expression of Wiskott-Aldrich syndrome protein family verprolin-homologous protein 2 correlated with poor prognosis of hepatocellular carcinoma.
Yang LY; Tao YM; Ou DP; Wang W; Chang ZG; Wu F
Clin Cancer Res; 2006 Oct; 12(19):5673-9. PubMed ID: 17020969
[TBL] [Abstract][Full Text] [Related]
8. Decreased expression of inhibitor of growth 4 correlated with poor prognosis of hepatocellular carcinoma.
Fang F; Luo LB; Tao YM; Wu F; Yang LY
Cancer Epidemiol Biomarkers Prev; 2009 Feb; 18(2):409-16. PubMed ID: 19208663
[TBL] [Abstract][Full Text] [Related]
9. Tumor associated glycoprotein-72 is a novel marker for poor survival in hepatocellular carcinoma.
Zhang Y; Deng ZS; Liao MM; Wang N; Zhang XQ; Yu HY; Zhang YD
Pathol Oncol Res; 2012 Oct; 18(4):911-6. PubMed ID: 22434316
[TBL] [Abstract][Full Text] [Related]
10. Overexpression of RhoA is associated with poor prognosis in hepatocellular carcinoma.
Li XR; Ji F; Ouyang J; Wu W; Qian LY; Yang KY
Eur J Surg Oncol; 2006 Dec; 32(10):1130-4. PubMed ID: 16806792
[TBL] [Abstract][Full Text] [Related]
11. Expression and prognostic significance of p21-activated kinase 6 in hepatocellular carcinoma.
Chen H; Miao J; Li H; Wang C; Li J; Zhu Y; Wang J; Wu X; Qiao H
J Surg Res; 2014 Jun; 189(1):81-8. PubMed ID: 24576777
[TBL] [Abstract][Full Text] [Related]
12. Neuron-glial antigen 2 overexpression in hepatocellular carcinoma predicts poor prognosis.
Lu LL; Sun J; Lai JJ; Jiang Y; Bai LH; Zhang LD
World J Gastroenterol; 2015 Jun; 21(21):6649-59. PubMed ID: 26074703
[TBL] [Abstract][Full Text] [Related]
13. Expressions of cysteine-rich61, connective tissue growth factor and Nov genes in hepatocellular carcinoma and their clinical significance.
Zeng ZJ; Yang LY; Ding X; Wang W
World J Gastroenterol; 2004 Dec; 10(23):3414-8. PubMed ID: 15526358
[TBL] [Abstract][Full Text] [Related]
14. Overexpression of activated Cdc42-associated kinase1 (Ack1) predicts tumor recurrence and poor survival in human hepatocellular carcinoma.
Wang B; Xu T; Liu J; Zang S; Gao L; Huang A
Pathol Res Pract; 2014 Dec; 210(12):787-92. PubMed ID: 25445114
[TBL] [Abstract][Full Text] [Related]
15. Downregulation of Mus81 as a novel prognostic biomarker for patients with colorectal carcinoma.
Wu F; Shirahata A; Sakuraba K; Kitamura Y; Goto T; Saito M; Ishibashi K; Kigawa G; Nemoto H; Sanada Y; Hibi K
Cancer Sci; 2011 Feb; 102(2):472-7. PubMed ID: 21175991
[TBL] [Abstract][Full Text] [Related]
16. Downregulation of KIF1B mRNA in hepatocellular carcinoma tissues correlates with poor prognosis.
Yang SZ; Wang JT; Yu WW; Liu Q; Wu YF; Chen SG
World J Gastroenterol; 2015 Jul; 21(27):8418-24. PubMed ID: 26217094
[TBL] [Abstract][Full Text] [Related]
17. miR-17-5p as a novel prognostic marker for hepatocellular carcinoma.
Chen L; Jiang M; Yuan W; Tang H
J Invest Surg; 2012 Jun; 25(3):156-61. PubMed ID: 22583011
[TBL] [Abstract][Full Text] [Related]
18. Overexpression of AGGF1 is correlated with angiogenesis and poor prognosis of hepatocellular carcinoma.
Wang W; Li GY; Zhu JY; Huang DB; Zhou HC; Zhong W; Ji CS
Med Oncol; 2015 Apr; 32(4):131. PubMed ID: 25796501
[TBL] [Abstract][Full Text] [Related]
19. Mus81 knockdown improves chemosensitivity of hepatocellular carcinoma cells by inducing S-phase arrest and promoting apoptosis through CHK1 pathway.
Wu F; Chen WJ; Yan L; Tan GQ; Li WT; Zhu XJ; Ge XC; Liu JW; Wang BL
Cancer Med; 2016 Feb; 5(2):370-85. PubMed ID: 26714930
[TBL] [Abstract][Full Text] [Related]
20. Prognostic significance of neuroepithelial transforming protein 1 in hepatocellular carcinoma.
Ye K; Wang Z; Zhang G; Liang S
J Invest Surg; 2010 Jun; 23(3):163-9. PubMed ID: 20590388
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
